Related references
Note: Only part of the references are listed.Detection of Free Peritoneal Cancer Cells in Gastric Cancer Using Cancer-Specific Newcastle Disease Virus
Joyce Wong et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
Itay Lazar et al.
JOURNAL OF VIROLOGY (2010)
Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
Jennifer Altomonte et al.
MOLECULAR THERAPY (2010)
Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
J. Puhlmann et al.
ONCOGENE (2010)
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
T. Schulze et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Genetically engineered Newcastle disease virus for malignant melanoma therapy
D. Zamarin et al.
GENE THERAPY (2009)
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
Dmitriy Zamarin et al.
MOLECULAR THERAPY (2009)
Time course of Newcastle disease virus-induced apoptotic pathways
P. V. Ravindra et al.
VIRUS RESEARCH (2009)
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
B. Yaacov et al.
CANCER GENE THERAPY (2008)
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
Richard E. Randall et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
Adam Vigil et al.
MOLECULAR THERAPY (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Use of reverse genetics to enhance the oncolytic properties of newcastle disease virus
Adam Vigil et al.
CANCER RESEARCH (2007)
Fusogenic vesicular stomatitis virus for the treatment of head and neck squamous carcinomas
Edward J. Shin et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2007)
An optimized clinical regimen for the oncolytic virus PV701
Sebastien J. Hotte et al.
CLINICAL CANCER RESEARCH (2007)
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus
Robert M. Lorence et al.
CURRENT CANCER DRUG TARGETS (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Separation of Anti-Proliferation and Anti-Apoptotic Functions of Retinoblastoma Protein through Targeted Mutations of Its A/B Domain
B. Nelson Chau et al.
PLOS ONE (2006)
Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death
Subbiah Elankumaran et al.
JOURNAL OF VIROLOGY (2006)
Tumor selective replication of Newcastle Disease Virus: Association with defects of tumor cells in antiviral defence
Christoph Fiola et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Influenza virus evades innate and adaptive immunity via the NS1 protein
Ana Fernandez-Sesma et al.
JOURNAL OF VIROLOGY (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1
Dmitriy Zamarin et al.
PLOS PATHOGENS (2005)
Attenuation of equine influenza viruses through truncations of the NS1 protein
M Quinlivan et al.
JOURNAL OF VIROLOGY (2005)
Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer
O Ebert et al.
CANCER RESEARCH (2004)
siRNA Selection Server: an automated siRNA oligonucleotide prediction server
BB Yuan et al.
NUCLEIC ACIDS RESEARCH (2004)
Prognostic significance of Bcl-xL in human hepatocellular carcinoma
J Watanabe et al.
SURGERY (2004)
Newcastle disease virus V protein is a determinant of host range restriction
MS Park et al.
JOURNAL OF VIROLOGY (2003)
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins
MS Park et al.
JOURNAL OF VIROLOGY (2003)
A time to kill: viral manipulation of the cell death program
S Hay et al.
JOURNAL OF GENERAL VIROLOGY (2002)
NS1 protein of influenza A virus down-regulates apoptosis
OP Zhirnov et al.
JOURNAL OF VIROLOGY (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
D Vucic et al.
CURRENT BIOLOGY (2000)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Newcastle disease virus (NDV): brief history of its oncolytic strains
JG Sinkovics et al.
JOURNAL OF CLINICAL VIROLOGY (2000)
Share Paper
